Sign In
Buy DYAI
$0.701
+0.0113 (+1.64%)
At Close: Jun 03, 2026
Dyadic International (NASDAQ:DYAI) Given Buy Rating at Noble Financial
04:00am, Tuesday, 30'th Jun 2020
Noble Financial reaffirmed their buy rating on shares of Dyadic International (NASDAQ:DYAI) in a research note published on Monday, TipRanks reports. Noble Financial currently has a $11.00 price objec
Dyadic International (DYAI) Receives a Buy from Noble Financial - Markets
08:06pm, Monday, 29'th Jun 2020
Noble Financial analyst Ahu Demir reiterated a Buy rating on Dyadic International (DYAI – Research Report) today and set a
Dyadic Joins Russell 2000(R) Index and Russell 3000(R) Index | | IT Business Net
12:12pm, Monday, 29'th Jun 2020
JUPITER, FL / ACCESSWIRE / June 29, 2020 / Dyadic International, Inc. ("Dyadic") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 ge
Dyadic Joins Russell 2000(R) Index and Russell 3000(R) Index
12:00pm, Monday, 29'th Jun 2020
JUPITER, FL / ACCESSWIRE / June 29, 2020 / Dyadic International, Inc. ("Dyadic") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression pla
This Revolutionary Biotech Is Shrouded in Mystery. Is It a Buy? | The Motley Fool
10:23am, Wednesday, 24'th Jun 2020
This small-cap stock is developing a technology that could revolutionize biotech.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Noble Financial Thinks Onconova Therapeutics' Stock is Going to Recover - Markets
11:56am, Monday, 15'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
Global Biocatalysis & Biocatalyst Market Trends, Forecast and Competitive Analysis to 2024 - ResearchAndMarkets.com
12:00am, Friday, 12'th Jun 2020
The
DYAI: Another Partnership, Another Step Closer to Immunizing the World
12:12pm, Thursday, 11'th Jun 2020
By John Vandermosten, CFA NASDAQ:DYAI Dyadic Announces Partnership with FNLCR Dyadic International, Inc. (NASDAQ:DYAI) announced in a press release yesterday that Frederick National Laboratory will us
6 Stocks And Targets To Watch
12:00am, Thursday, 11'th Jun 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Ballard Power Systems Inc, Tesla Inc, Riot Blockchain Inc. Read Harry Boxer's latest article on Investing.com
Noble Financial Keeps a Buy Rating on Dyadic International (DYAI) - Markets
09:18pm, Wednesday, 10'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Dyadic International (DYAI – Research
Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic's C1 Gene Expression Platform
12:30pm, Wednesday, 10'th Jun 2020
JUPITER, FL / ACCESSWIRE / June 10, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 ge
DYAI: Steady as She Goes
10:10am, Friday, 29'th May 2020
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT First Quarter Financial & Operational Results Dyadic International Inc. (NASDAQ: DYAI) released first quarter financial and ope
Hedge Funds Cashed Out Of Dyadic International, Inc. (DYAI)
04:43pm, Wednesday, 27'th May 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
